In brief, our results showed Ash2l modulated PPARγ transcription activation through increasing promoter enrichment, which led to the upregulation of the direct PPARγ target genes in ECs, especially of OLR-1 and CD36, correspondingly increased the uptake and accumulation of oxidized lipids and aggravated atherosclerosis. Here, ASH2L is linked to atherosclerosis.